Daniel J Lee, Chungah Kim, Mauz Asghar, John M Lee, Jasmin Kantarevic, Lyn M Sibley, Yvonne Chan
{"title":"手术病例量影响鼻内窥镜手术翻修率。","authors":"Daniel J Lee, Chungah Kim, Mauz Asghar, John M Lee, Jasmin Kantarevic, Lyn M Sibley, Yvonne Chan","doi":"10.1002/alr.23602","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Previous studies have demonstrated a positive relationship between surgeon volume and patient outcomes. While this relationship has been established in oncologic, bariatric, and orthopedic surgeries, little is known in the realm of endoscopic sinus surgery (ESS). The objective was to assess the association between a surgeon's ESS annual volume and rates of revision surgery within 5 years as well as 30-day complications for patients with chronic rhinosinusitis (CRS).</p><p><strong>Methods: </strong>We identified CRS patients in Ontario, Canada, who underwent primary ESS, using surgeon-level administrative data between 2014 and 2018 (N = 13,562). Surgeon volume was calculated based on the number of procedures performed in the previous year by the surgeon and was divided into quartiles. We identified those who underwent revision ESS within the subsequent 5-year period. Complications were defined as unplanned hospital admission or emergency department visit within the first 30 days following the operation. A multivariate regression model was used to estimate the effect of surgeon volume on revision rate.</p><p><strong>Results: </strong>An unadjusted model demonstrated that high surgeon volume quartile (> 63/year) was associated with lower rates of revision surgery and 30-day hospitalization (p < 0.05 for both) along with a higher rate of complete ESS (p < 0.001). After controlling for patient/surgeon covariates and extent of ESS, low-volume surgeons (1-17/year) remained an independent statistically significant predictor of revision surgery (hazard ratios [HR]: 1.60, 95% confidence interval [CI]: 1.17-2.19).</p><p><strong>Conclusion: </strong>Our study is the first to demonstrate a surgeon volume-outcome relationship in ESS. Being a high-volume surgeon is predictive of a lower revision rate in CRS patients undergoing ESS.</p>","PeriodicalId":13716,"journal":{"name":"International Forum of Allergy & Rhinology","volume":" ","pages":"e3602"},"PeriodicalIF":7.2000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Surgeon Case Volume Impacts Revision Rate of Endoscopic Sinus Surgery.\",\"authors\":\"Daniel J Lee, Chungah Kim, Mauz Asghar, John M Lee, Jasmin Kantarevic, Lyn M Sibley, Yvonne Chan\",\"doi\":\"10.1002/alr.23602\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Previous studies have demonstrated a positive relationship between surgeon volume and patient outcomes. While this relationship has been established in oncologic, bariatric, and orthopedic surgeries, little is known in the realm of endoscopic sinus surgery (ESS). The objective was to assess the association between a surgeon's ESS annual volume and rates of revision surgery within 5 years as well as 30-day complications for patients with chronic rhinosinusitis (CRS).</p><p><strong>Methods: </strong>We identified CRS patients in Ontario, Canada, who underwent primary ESS, using surgeon-level administrative data between 2014 and 2018 (N = 13,562). Surgeon volume was calculated based on the number of procedures performed in the previous year by the surgeon and was divided into quartiles. We identified those who underwent revision ESS within the subsequent 5-year period. Complications were defined as unplanned hospital admission or emergency department visit within the first 30 days following the operation. A multivariate regression model was used to estimate the effect of surgeon volume on revision rate.</p><p><strong>Results: </strong>An unadjusted model demonstrated that high surgeon volume quartile (> 63/year) was associated with lower rates of revision surgery and 30-day hospitalization (p < 0.05 for both) along with a higher rate of complete ESS (p < 0.001). After controlling for patient/surgeon covariates and extent of ESS, low-volume surgeons (1-17/year) remained an independent statistically significant predictor of revision surgery (hazard ratios [HR]: 1.60, 95% confidence interval [CI]: 1.17-2.19).</p><p><strong>Conclusion: </strong>Our study is the first to demonstrate a surgeon volume-outcome relationship in ESS. Being a high-volume surgeon is predictive of a lower revision rate in CRS patients undergoing ESS.</p>\",\"PeriodicalId\":13716,\"journal\":{\"name\":\"International Forum of Allergy & Rhinology\",\"volume\":\" \",\"pages\":\"e3602\"},\"PeriodicalIF\":7.2000,\"publicationDate\":\"2025-05-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Forum of Allergy & Rhinology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/alr.23602\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OTORHINOLARYNGOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Forum of Allergy & Rhinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/alr.23602","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
Surgeon Case Volume Impacts Revision Rate of Endoscopic Sinus Surgery.
Introduction: Previous studies have demonstrated a positive relationship between surgeon volume and patient outcomes. While this relationship has been established in oncologic, bariatric, and orthopedic surgeries, little is known in the realm of endoscopic sinus surgery (ESS). The objective was to assess the association between a surgeon's ESS annual volume and rates of revision surgery within 5 years as well as 30-day complications for patients with chronic rhinosinusitis (CRS).
Methods: We identified CRS patients in Ontario, Canada, who underwent primary ESS, using surgeon-level administrative data between 2014 and 2018 (N = 13,562). Surgeon volume was calculated based on the number of procedures performed in the previous year by the surgeon and was divided into quartiles. We identified those who underwent revision ESS within the subsequent 5-year period. Complications were defined as unplanned hospital admission or emergency department visit within the first 30 days following the operation. A multivariate regression model was used to estimate the effect of surgeon volume on revision rate.
Results: An unadjusted model demonstrated that high surgeon volume quartile (> 63/year) was associated with lower rates of revision surgery and 30-day hospitalization (p < 0.05 for both) along with a higher rate of complete ESS (p < 0.001). After controlling for patient/surgeon covariates and extent of ESS, low-volume surgeons (1-17/year) remained an independent statistically significant predictor of revision surgery (hazard ratios [HR]: 1.60, 95% confidence interval [CI]: 1.17-2.19).
Conclusion: Our study is the first to demonstrate a surgeon volume-outcome relationship in ESS. Being a high-volume surgeon is predictive of a lower revision rate in CRS patients undergoing ESS.
期刊介绍:
International Forum of Allergy & Rhinologyis a peer-reviewed scientific journal, and the Official Journal of the American Rhinologic Society and the American Academy of Otolaryngic Allergy.
International Forum of Allergy Rhinology provides a forum for clinical researchers, basic scientists, clinicians, and others to publish original research and explore controversies in the medical and surgical treatment of patients with otolaryngic allergy, rhinologic, and skull base conditions. The application of current research to the management of otolaryngic allergy, rhinologic, and skull base diseases and the need for further investigation will be highlighted.